GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DuoGenic StemCells Corp (ROCO:7607) » Definitions » Accounts Payable

DuoGenic StemCells (ROCO:7607) Accounts Payable : NT$0.11 Mil (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is DuoGenic StemCells Accounts Payable?

DuoGenic StemCells's Accounts Payable for the quarter that ended in Jun. 2024 was NT$0.11 Mil.

DuoGenic StemCells's quarterly Accounts Payable declined from Jun. 2023 (NT$0.19 Mil) to Dec. 2023 (NT$0.10 Mil) but then increased from Dec. 2023 (NT$0.10 Mil) to Jun. 2024 (NT$0.11 Mil).

DuoGenic StemCells's annual Accounts Payable increased from Dec. 2021 (NT$0.09 Mil) to Dec. 2022 (NT$0.21 Mil) but then declined from Dec. 2022 (NT$0.21 Mil) to Dec. 2023 (NT$0.10 Mil).


DuoGenic StemCells Accounts Payable Historical Data

The historical data trend for DuoGenic StemCells's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DuoGenic StemCells Accounts Payable Chart

DuoGenic StemCells Annual Data
Trend Dec21 Dec22 Dec23
Accounts Payable
0.09 0.21 0.10

DuoGenic StemCells Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Accounts Payable Get a 7-Day Free Trial - 0.21 0.19 0.10 0.11

DuoGenic StemCells Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


DuoGenic StemCells Accounts Payable Related Terms

Thank you for viewing the detailed overview of DuoGenic StemCells's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


DuoGenic StemCells Business Description

Traded in Other Exchanges
N/A
Address
Room R207, Innovation Incubation Center, 145, Xingda Road, South District, Taichung, TWN
DuoGenic StemCells Corp is a company having a team of passionate researchers focused on stem cell cultivation. Their products are intended for research use and can be upgraded for clinical applications. It also develops blood cell therapy programs, using the isolation and purification of blood mononuclear cells to remove granule cells that promote inflammation, and conducts clinical trials on various degenerative diseases to provide a convenient and simple new option for cell therapy.

DuoGenic StemCells Headlines

No Headlines